CAR-T cell therapy targeting CLL-1 and CD38
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T cell therapy targeting CLL-1 and CD38, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]